Wall Street Journal
The maker of the widely used Avastin cancer drug said Tuesday that it is warning doctors, hospitals and patient groups that a counterfeit version of the medicine has been found in the U.S.
Tests of counterfeit vials of Avastin showed that they didn't contain the active ingredient inAG's intravenous drug, according to the Swiss company's Genentech unit.
It isn't clear how much of the counterfeit product was distributed in
the U.S. or whether it has caused any harm. A Genentech spokeswoman
said the company doesn't know if any patients were given the fake drug... Read More